Profile: Optivus Proton Therapy, Inc specializes in proton therapy technology. The proton beam therapy is a painless and noninvasive form of radiation therapy used to treat cancer. Protons are stable, positively charged subatomic particles with a mass, 1,800 times greater than that of photons. These characteristics allow the proton's dose of radiation to be controlled in 3 dimensions to the exact shape and depth of the tumor within the body. This therapy is ideal for tumors in or near critical structures such as the brain, heart, optic nerve or spinal cord, that are inoperable, and cannot tolerate much radiation. We offer Conforma 300® and synchrotron accelerator. The Conforma 3000 is a flexible and precise proton therapy system with modular design. Our synchrotron accelerator is the core of the Conforma 3000 system for use in clinical environment on proton beam therapy. We also offer image guided and intensity modulated proton therapy solutions. Our intensity modulated proton therapy allows a physician to vary dosage intensity within a single target using a narrow proton beam, which is painted across a target from multiple directions, while depositing the radiation dose.
The company was founded in 1993, has revenues of USD 5-10 Million, has ~80 employees and is ISO 9001 certified.
FDA Registration Number: 2032229
2 Products/Services (Click for related suppliers)
|• Medical Charged-Particle Radiotherapy Unit (FDA Code: LHN / 892.5050)|
|• Medical Synchrotron (FDA Code: IWM / 892.5050)|